This application is directed to suture-free stent grafts and stent graft constructs and methods for forming suture-free stent grafts and stent graft constructs. More particularly, this application is directed to suture-free stent grafts and stent graft constructs and methods for forming suture-free stent grafts and stent graft constructs having integrated extensions.
Stent grafts are important abluminal cardiovascular device constructs important to both structural heart assignments such as transcatheter heart valves as well as aortic and vascular stenting. However, the state of the art is primitive and depends on suture ligation to permanently fix the textile graft to the stenting scaffold. Suture ligation for fixing a textile graft to a stenciling scaffold has many disadvantages, including: a high economic burden for the manual suturing process, abluminal vascular wall trauma and aortic wall injury (including scratches, abrasions, endoleakage, aortic wall dissention, aneurysms, infections, abluminal intimal hyperplasia, fibrosis, wall stiffening, inflammation, disruption of hemodynamic flow, and nickel/metal leaching), abrasion and scuffing of the stent-graft sutures with the endothelial abluminal surface during deployment and in service.
There is a need for stent grafts which do not suffer from these disadvantages.
In one exemplary embodiment, a suture-free stent graft includes a woven graft tube having an inner face and an outer face and a plurality of woven extensions extending from the outer face of the woven graft tube. Each of the plurality of woven extensions is integrally woven with the woven graft tube at a first end and a second end such that warp from the woven graft tube is de-interlaced from the woven graft tube at the first end and re-interlaced with the woven graft tube at the second end. Supplemental warp is interlaced into the woven graft tube in replacement of the deinterlaced warp so as to maintain weave density in the woven graft tube under the plurality of woven extensions. The plurality of woven extensions and portions of the woven graft tube disposed directly under the plurality of woven extension have independent weft from one another.
In another exemplary embodiment, a suture-free stent graft construct includes a suture-free stent graft and at least one stent wire disposed about the suture-free stent graft. The suture-free stent graft includes a woven graft tube having an inner face and an outer face and a plurality of woven extensions extending from the outer face of the woven graft tube. Each of the plurality of woven extensions is integrally woven with the woven graft tube at a first end and a second end such that warp from the woven graft tube is de-interlaced from the woven graft tube at the first end and re-interlaced with the woven graft tube at the second end. Supplemental warp is interlaced into the woven graft tube in replacement of the deinterlaced warp so as to maintain weave density in the woven graft tube under the plurality of woven extensions. The plurality of woven extensions and portions of the woven graft tube disposed directly under the plurality of woven extension have independent weft from one another. The at least one stent wire is at least partially disposed between the woven graft tube and the plurality of woven extensions at a plurality of securement sites, securing the woven graft tube to the at least one stent wire.
Further aspects of the subject matter of the present disclosure are provided by the following clauses:
A suture-free stent graft includes a woven graft tube having an inner face and an outer face and a plurality of woven extensions extending from the outer face of the woven graft tube. Each of the plurality of woven extensions is integrally woven with the woven graft tube at a first end and a second end such that warp from the woven graft tube is de-interlaced from the woven graft tube at the first end and re-interlaced with the woven graft tube at the second end. Supplemental warp is interlaced into the woven graft tube in replacement of the deinterlaced warp so as to maintain weave density in the woven graft tube under the plurality of woven extensions. The plurality of woven extensions and portions of the woven graft tube disposed directly under the plurality of woven extension have independent weft from one another.
The suture-free stent graft of any preceding clause, wherein the suture-free stent graft is free of floating yarns forming the plurality of woven extensions.
The suture-free stent graft of any preceding clause, wherein each of the plurality of woven extensions has only woven edges except where interlaced and integral with the woven graft tube.
The suture-free stent graft of any preceding clause, wherein the plurality of woven extensions include loop extensions integral with the woven graft tube at only the first end and the second end, defining a plurality of through-channels.
The suture-free stent graft of any preceding clause, wherein the plurality of woven extensions include slot extensions integral with the woven graft tube at the first end and the second end as well as along one edge extending from the first end to the second end, defining a plurality of pockets.
The suture-free stent graft of any preceding clause, wherein the woven graft tube is formed of 20-40 denier yarn and includes at least 150 ends per inch and at least 100 picks per inch throughout the woven graft tube.
The suture-free stent graft of any preceding clause, wherein the 20-40 denier yarn is polyethylene terephthalate yarn.
The suture-free stent graft of any preceding clause, wherein the plurality of woven extensions is positioned along and about, and oriented relative to, the woven graft tube so as to receive at least one stent wire having a predetermined shape.
A suture-free stent graft construct includes a suture-free stent graft and at least one stent wire disposed about the suture-free stent graft. The suture-free stent graft includes a woven graft tube having an inner face and an outer face and a plurality of woven extensions extending from the outer face of the woven graft tube. Each of the plurality of woven extensions is integrally woven with the woven graft tube at a first end and a second end such that warp from the woven graft tube is de-interlaced from the woven graft tube at the first end and re-interlaced with the woven graft tube at the second end. Supplemental warp is interlaced into the woven graft tube in replacement of the deinterlaced warp so as to maintain weave density in the woven graft tube under the plurality of woven extensions. The plurality of woven extensions and portions of the woven graft tube disposed directly under the plurality of woven extension have independent weft from one another. The at least one stent wire is at least partially disposed between the woven graft tube and the plurality of woven extensions at a plurality of securement sites, securing the woven graft tube to the at least one stent wire.
The suture-free stent graft construct of any preceding clause, wherein the plurality of woven extensions include loop extensions integral with the woven graft tube at only the first end and the second end, defining a plurality of through-channels, and the at least one stent wire passes through the plurality of through-channels.
The suture-free stent graft construct of any preceding clause, wherein the plurality of woven extensions include slot extensions integral with the woven graft tube at the first end and the second end as well as along one edge extending from the first end to the second end, defining a plurality of pockets, and the at least one stent wire is partially disposed within the plurality of pockets.
Wherever possible, the same reference numbers will be used throughout the drawings to represent the same parts.
Unless otherwise specified, “about” indicates a variance of ±5% from the value being modified.
Embodiments of the present invention provide suture-free stent grafts and stent graft constructs and methods for forming suture-free stent grafts and stent graft constructs with integrated extensions. Embodiments of the present invention, in comparison to existing solutions lacking at least one of the features disclosed herein, represent a more advanced approach than known solutions for stent grafts and stent graft constructs and demonstrate a break away from traditional engineering designs and the advancement of interfacial surface bonding technologies to reduce or eliminate the dangers of knotted ligature in stent grafts, reduce or eliminate nickel leaching, reduce or eliminate fibrotic immune system response, or combinations thereof Further, embodiments of the present invention, in comparison to existing solutions lacking at least one of the features disclosed herein, may extend the service stent grafts, including, but not limited to, aortic stents, by reducing a patient's natural response to foreign materials and trauma.
Textile interfaces currently using ligatures may be replaced with textile grafts of polyethylene terephthalate (“PET”), polyvinylidene fluoride (“PVDF”), ultra-high molecular weight polyethylene (“UHMWPE”), polyethersulfone (“PES”), polypropylene (“PP”), polytetrafluoroethylene (“PTFE”), thermoplastic polyurethane (“TPU”), or combinations thereof, alone or in combination with polymeric biodegradable glycerol ester chemistries (poly(glycerol sebacate) (“PGS”), poly(glycerol-co-sebacate) acrylate (“PGSA”), poly(glycerol sebacate urethane) (“PGSU”), poly(glycerol sebacate)-co-poly(glycolic acid) (“PGS-co-PGA”), poly(glycerol sebacate)-co-poly(lactic acid) (“PGS-co-PLA”)) as bonding agents for textile interfaces where ligatures exist.
Referring to
Adding the supplemental warp 1 may maintain a targeted liquid tightness in the woven graft tube 100 by counteracting the decreased density of warp 1 that are being lifted off the woven graft tube 100 to form the plurality of woven extensions 106. In a comparative example which is otherwise identical but without adding the supplemental warp 1, the density of the woven graft tube 100 where the warp 1 has been lifted away to form the plurality of woven extensions 106 would be decreased, increasing porosity and leakage, and the resulting floating warp 1 or weft 2, particularly warp 1 or weft 2 that would not be interlaced, may lead to snagging or pulling of the ends or picks as a stent wire 112 is threaded through the suture-free stent graft 10.
The suture-free stent graft 10 may be free of floating yarns forming the plurality of woven extensions 106. Each of the plurality of woven extensions 106 may have only woven edges 114 except where interlaced and integral with the woven graft tube 100.
Referring to
Referring to
Referring to
Referring to
Referring to
The woven extension 106 may be oriented in the cross-machine direction 130 of the loom (
The woven graft tube 100 may be formed of any suitable yarn, including, but not limited to, 16-44 denier yarn, alternatively 16-24 denier yarn, alternatively 20-28 denier yarn, alternatively 24-32 denier yarn, alternatively 28-36 denier yarn, alternatively 32-40 denier yarn, alternatively 36-44 denier yarn, alternatively 20-40 denier yarn, alternatively 16 denier yarn, alternatively 20 denier yarn, alternatively 40 denier yarn, or any subrange or combination thereof The yarn may have any suitable composition, including, but not limited to, PET, PVDF, UHMWPE, PES, PP, PTFE, TPU, or combinations thereof.
The plurality of woven extensions 106 may be formed of any suitable yarn, including, but not limited to, 16-44 denier yarn, alternatively 16-24 denier yarn, alternatively 20-28 denier yarn, alternatively 24-32 denier yarn, alternatively 28-36 denier yarn, alternatively 32-40 denier yarn, alternatively 36-44 denier yarn, alternatively 20-40 denier yarn, alternatively 16 denier yarn, alternatively 20 denier yarn, alternatively 40 denier yarn, or any subrange or combination thereof. The yarn may have any suitable composition, including, but not limited to, PET.
In one embodiment, the woven graft tube 100 includes at least 100 ends per inch and at least 100 picks per inch throughout the woven graft tube, alternatively 150 ends per inch and at least 100 picks per inch, alternatively at least 200 ends per inch and at least 150 picks per inch, alternatively 100-350 ends per inch and 100-240 picks per inch, alternatively 100-200 ends per inch and 100-150 picks per inch, alternatively 150-250 ends per inch and 125-175 picks per inch, alternatively 200-300 ends per inch and 150-200 picks per inch, alternatively 250-350 ends per inch and 175-240 picks per inch, or any sub-range or combination thereof.
In one embodiment, the plurality of woven extensions 106 includes at least 50 ends per inch and at least 50 picks per inch throughout the plurality of woven extensions, alternatively at least 150 ends per inch and at least 100 picks per inch, alternatively at least 200 ends per inch and at least 150 picks per inch, alternatively 50-350 ends per inch and 50-240 picks per inch, alternatively 50-150 ends per inch and 50-110 picks per inch, alternatively 100-200 ends per inch and 80-140 picks per inch, alternatively 150-250 ends per inch and 110-170 picks per inch, alternatively 200-300 ends per inch and 140-200 picks per inch, alternatively 250-350 ends per inch and 170-240 picks per inch or any sub-range or combination thereof.
Referring to
The stent wire 112 may be made from any suitable material, including, but not limited to, a nickel-titanium alloy (“nitinol”) having a nickel:titanium alloy of about 4:5 to about 2:3.
The woven extensions 106 may be secured in place over the at least one stent wire 112 by any suitable adherent system, including, but not limited to, polymeric biodegradable glycerol esters (PGS, PGSA, PGSU, PGS-co-PGA, PGS-co-PLA, or combinations thereof), chelating polymers (such as, but not limited to, catechol-modified polymeric biodegradable glycerol ester), primers, bonding agents, or combinations thereof. The adherent system may also passivate the at least one stent wire 112. The adherent system may be characterized by elastomeric interfacial bonding between the at least one stent wire 112 and the underlying woven graft tube 100.
Referring to
In one embodiment, a method for forming a suture-free stent graft 10 includes weaving a multilayered, multifilament graft 10 including a woven graft tube 100 and a plurality of woven extensions 106 extending from an outer face 104 of the woven graft tube 100. Each of the plurality of woven extensions 106 is integrally woven with the woven graft tube 100 at a first end 108 and a second end 110 such that warp 1 from the woven graft tube 100 is de-interlaced from the woven graft tube 100 at the first end 108 and re-interlaced with the woven graft tube 100 at the second end 110. Supplemental warp 1 is interlaced into the woven graft tube 100 in replacement of the deinterlaced warp 1 so as to maintain weave density in the woven graft tube 100 under the plurality of woven extensions 106. The woven graft tube 100 and the plurality of woven extensions 106 have independent weft 2 from one another. The plurality of woven extensions 106 protrudes over the woven graft tube 100 and create a through-channel 118 or pocket 124 of fabric independent of the outer face 104 of the woven graft tube 100 such that the through-channel 118 or pocket 124 shares no common warp 1 or weft threads 2 with the woven graft tube 100 directly below the through-channel 118 or pocket 124. In a further embodiment, the suture-free stent graft 10 is formed using a shuttle loom that may form clean uncut woven edges 114 on the woven graft tube 100 and the plurality of woven extensions 106 which mitigates fraying in the machine direction 128. In order to increase the protrusion of the plurality of woven extensions 106 above the woven graft tube 100 (and thereby enhance the separation), the ratio of weft 2 to warp 1 may be increased, the size of the weft 2 yarn may be increased, a different material, such as, but not limited to, monofilament yarn may be added or substituted, or combinations thereof.
Referring to
In a first step, shuttle B was engaged to weave the top tubular ground for a minimum of two picks then shuttle C was engaged to weave only with supplemental warp on the front left side of the tube for a minimum of one pick. This sequence was repeated until the desired length of loop was formed (four picks of shuttle B to two picks of shuttle C in the present example). In a second step, shuttle B was engaged to weave the tubular warp ends and the supplemental warp that form the back face, left loop to form an attachment of loop to the back tubular ground for a minimum of four picks. Shuttle B continued to weave to interlace the top tubular warp ends and supplemental warp of the front face, left loop for a minimum of four picks. In a third step, shuttle B was engaged to weave the tubular ground for a minimum of two picks and then shuttle C was engaged to weave only with the supplemental warp on the back left face of tube for a minimum of one pick and repeat this step until desired length of loop was woven (four picks of shuttle B to two picks of shuttle C in the present example). In a fourth step, shuttle B was engaged to weave the tubular warp ends and the supplemental warp that form the front face, right loop to form an attachment of loop to top tubular ground for a minimum of four picks. Shuttle B continued to weave to interlace the back tubular warp ends and supplemental warp of the back face, left loop for a minimum of four picks. In a fifth step, shuttle B was engaged to weave the tubular ground for a minimum of two picks then shuttle A was engaged to weave only with the supplemental warp on the front face right side of the tube for a minimum of one pick. This sequence was repeated until the desired length of loop was formed (four picks of shuttle B to two picks of shuttle A in the present example). In a sixth step, shuttle B was engaged to weave the tubular warp ends and the supplemental warp that form the back face right loop to form an attachment of loop to the back tubular ground for a minimum of four picks. Shuttle B continued to weave to interlace the top tubular warp ends and supplemental warp of the front face, right loop for a minimum of four picks. In a seventh step, shuttle B was engaged to weave the tubular ground for a minimum of two picks then shuttle A was engaged to weave only with the supplemental warp on the back face right side of the tube for a minimum of one pick. This sequence was repeated until the desired length of loop was formed (four picks of shuttle B to two picks of shuttle A in the present example). In an eighth step, shuttle B was engaged to weave the tubular warp ends and the supplemental warp that form the front face left loop to form an attachment of loop to the top tubular ground for a minimum of four picks. Shuttle B continued to weave to interlace the back tubular warp ends and supplemental warp of the back face, right loop for a minimum of four picks. Although in this example, the supplemental warp was floating on the top face of the suture-free stent graft 10, the supplemental warp may also float behind the top tubular face within the woven graft tube 100 itself. Similarly, the entire suture-free stent graft may be woven inside-out.
The suture-free stent graft 10 as woven in this example is shown in
While the foregoing specification illustrates and describes exemplary embodiments, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this invention, but that the invention will include all embodiments falling within the scope of the appended claims.
This application claims the benefit of and priority to U.S. Provisional Patent Application No. 63/362,766, filed Apr. 11, 2022, entitled “Suture-Free Stent Grafts and Stent Graft Constructs with Integrated Extensions and Methods for Forming,” and U.S. Provisional Patent Application No. 63/362,762, filed Apr. 11, 2022, entitled “Articles, Compositions, and Methods for Sutureless Implants,” which are hereby incorporated by reference in their entirety.
Number | Date | Country | |
---|---|---|---|
63362766 | Apr 2022 | US | |
63362762 | Apr 2022 | US |